HLA-Shuttle exploits the widespread down-regulation of tapasin in cancers, both restoring tapasin expression in these cells while additionally stabilizing HLA-I molecules through its extra-ER activity, thereby providing a continuum of chaperoning activity across the secretory pathway. The gene discussed is TAPBP; the disease is cancer.